Elevated levels of IL-6 in the plasma of obese rodents compared with lean rats sensitized breast cancer cells to reduced testosterone levels (Fig. 8C),198 demonstrating how cytokines and growth factors associated with obesity can influence the response of breast cancer tumors to steroid hormones and hormonal therapy, regardless of subtypes. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.